BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17063438)

  • 1. [Hepatocyte growth factor and kidney].
    Esposito C; Fasoli G; Rampino T; Dal Canton A
    G Ital Nefrol; 2006; 23(4):381-8. PubMed ID: 17063438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth.
    Esposito C; Parrilla B; Cornacchia F; Grosjean F; Mangione F; Serpieri N; Valentino R; Villa L; Arra M; Esposito V; Dal Canton A
    Growth Factors; 2009 Jun; 27(3):173-80. PubMed ID: 19301208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression.
    Liu Y; Centracchio JN; Lin L; Sun AM; Dworkin LD
    Exp Cell Res; 1998 Jul; 242(1):174-85. PubMed ID: 9665815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
    Liu Y
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F7-16. PubMed ID: 15180923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta.
    Santos OF; Nigam SK
    Dev Biol; 1993 Dec; 160(2):293-302. PubMed ID: 8253265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
    Mou S; Wang Q; Shi B; Gu L; Ni Z
    Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocyte growth factor (HGF) reduces the expression of profibrotic factors in human isolated glomeruli].
    Esposito C; Parilla B; De Mauri A; Cornacchia F; Fasoli G; Foschi A; Mazzullo T; Plati AR; Scudellaro R; Dal Canton A
    G Ital Nefrol; 2003; 20(4):376-80. PubMed ID: 14523898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H; Naujokas MA; Park M
    Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
    Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC
    Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region.
    Inoue T; Nabeshima K; Shimao Y; Koono M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):225-31. PubMed ID: 10381371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts.
    Schievenbusch S; Strack I; Scheffler M; Wennhold K; Maurer J; Nischt R; Dienes HP; Odenthal M
    Biochem Biophys Res Commun; 2009 Jul; 385(1):55-61. PubMed ID: 19426716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J; Dai C; Liu Y
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture.
    Naim R; Chang RC; Alfano SS; Riedel F; Bayerl C; Sadick H; Bran G; Hormann K
    Regul Pept; 2005 Aug; 130(1-2):75-80. PubMed ID: 15913806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R; Zhang X; Yang J; Li Y; Liu Y
    J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death.
    Liu Y; Sun AM; Dworkin LD
    Biochem Biophys Res Commun; 1998 May; 246(3):821-6. PubMed ID: 9618296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of TGF-beta and hepatocyte growth factor in kidney tissues of children with primary focal segmental glomerular sclerosis].
    Wei MJ; Wu WL; Chen MY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):630-3. PubMed ID: 20704796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.
    Matsumoto K; Nakamura T
    Crit Rev Oncog; 1992; 3(1-2):27-54. PubMed ID: 1312869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.